Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Celula logo — Enhancing reproductive health with innovative, cost-effectiv...

Celula

Enhancing reproductive health with innovative, cost-effective IVD solutions for accurate patient detection and inspector convenience.

Founded 2013 Series B Total: $53.00M Biotechnology, Life Sciences +2

General Information

Company Name Celula
Founded Year 2013
Industries Biotechnology, Life Sciences, Manufacturing +1
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Celula. To contact Celula, visit celula-china.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Celula compare?

A PDF of Celula and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Celula soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Celula

Celula is a healthcare company established in 2013, specializing in in-vitro diagnostics (IVD) products. The company's slogan "Enhancing reproductive health with innovative, cost-effective IVD solutions for accurate patient detection and inspector convenience" reflects its focus on reproductive health and commitment to offering integrated and budget-friendly IVD solutions. By aligning with clinical requirements, Celula provides precise diagnostic solutions to patients and equips professionals with user-friendly, advanced products. Having received a CNY50.00M Series B investment on 01 September 2020 from Hanne Capital, Celula has demonstrated its attractiveness to investors, showcasing potential for growth and development within the Biotechnology, Life Sciences, Manufacturing, and Medical Devices industries. The investment further strengthens Celula's position within the market, supporting its mission to enhance reproductive health through innovation and accessibility in IVD solutions.

Business keywords: reproductive health, in-vitro diagnostics, IVD products, clinical requirements, diagnostic solutions, health products, health diagnostics

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B CNY50.00M 1
Hanne Capital
Hanne Capital
01 Sep 2020
Angel Round CNY3.00M 3
BIOCHING CAPITAL CDB Capital CD Capital
BIOCHING CAPITAL, CDB Capital +1
09 Oct 2018

Celula Alternatives & Competitors

View All Alternatives
Celula vs
Aidian
Aidian Finland

Aidian develops, manufactures and markets diagnostic tests and test solutions.

Venture round
205 employees
Biotechnology, Health Care
Celula vs
Generex Biotechnology Corporation
Generex Biotechnology Corporation United States

An integrated healthcare holding company with end-to-end solutions for patient-centric care.

Post-IPO Equity
14 employees
Biopharma, Biotechnology
Celula vs
Daktari Diagnostics
Daktari Diagnostics United States

Delivering critical diagnostic solutions to resource-poor markets with a commitment to quality, affo...

Grant
7 employees
Biotechnology, Health Care
Also compare with: Celula vs J Mitra & Co Pvt Ltd J Mitra & Co Pvt Ltd View all alternatives

FAQ About Celula

Enhancing reproductive health with innovative, cost-effective IVD solutions for accurate patient detection and inspector convenience.
Celula was founded in 2013.
Celula operates in Biotechnology, Life Sciences, Manufacturing and Medical Devices. Its work centres on reproductive health, in-vitro diagnostics, IVD products and clinical requirements.
Celula has completed 2 funding rounds, raising a total of $53.00M. The latest funding stage is Series B.
Top alternatives and competitors to Celula include Aidian, Generex Biotechnology Corporation, Daktari Diagnostics, Surmodics, Inc., Quidel. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Celula and Aidian are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Celula, https://www.bouncewatch.com/company/celula, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout